Abiopharma

🔍 Curry Mary Margaret (Executive)

Company: COMSCORE, INC. (SCOR)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Acquired 60,000 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-20 | Code: A | equity_swap_involved: 0 | shares_owned_after: 60,000.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Acquired 60,000 shares of Stock Option (right to buy) at $5.1 per share (Derivative)
  Date: 2026-08-20 | Code: A | Expires: 2036-08-20 | equity_swap_involved: 0 | shares_owned_after: 60,000.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
• F2: This restricted stock unit award was granted pursuant to the terms of the comScore, Inc. 2018 Equity and Incentive Compensation Plan. This award vests in four equal annual installments beginning on 8/20/2027 subject to the reporter's continued service with the Company through each vesting date. Vested units will be deferred and delivered in shares of common stock on the earlier of a separation from service or a change in control of the Company, as set forth in the applicable award agreement.
• F3: This option award was granted pursuant to the terms of the comScore, Inc. 2018 Equity and Incentive Compensation Plan and vests and becomes exercisable in four equal annual installments beginning on 8/20/2027, subject to the reporter's continued service with the Company through each vesting date.
• REMARKS: Chief Financial Officer and Treasurer